Anti-inflammatory and antiapoptotic effect of interleukine-18 binding protein on the spinal cord ischemia-reperfusion injury

Inflammation

Volumn 37, Issue 3, 2014, Pages 917-923

  Karavelioğlu, Ergün ^a   Gönül, Yücel ^a   Kokulu, Serdar ^a   Hazman, Ömer ^a   Bozkurt, Fatih ^a   Koçak, Ahmet ^b   Eser, Olcay ^c  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b DUMLUPINAR UNIVERSITY   (Turkey)

^c BALIKESIR UNIVERSITY   (Turkey)

Author keywords

caspase 3; cytokines; interleukin 18 binding protein; ischemia reperfusion; spinal cord

Indexed keywords

CASPASE 3; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; APOPTOSIS REGULATORY PROTEIN; INTERLEUKIN-18 BINDING PROTEIN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; SPINAL CORD; SPINAL CORD ISCHEMIA; ANIMAL; BLOOD; DISEASE MODEL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASE 3; CYTOKINES; DISEASE MODELS, ANIMAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-18; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902543393     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-9811-7     Document Type: Article

References (40)

1. Baki, E.D., M. Aldemir, S. Kokulu, H.B. Koca, Y. Ela, R.G. Sivaci, N.K. Ozturk, M. Emmiler, F. Adali, and H. Uzel. 2013. Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and S100β protein during coronary artery bypass grafting. Inflammation 36(6): 1327-1333.
2. Banda, Nirmal K., Vondracek Andrea, Kraus Damian, Charles A. Dinarello, Kim Soo-Hyun, Bendele Alison, Senaldi Giorgio, and William P. Arend. 2003. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. Journal of Immunology 170: 2100-2105. Baltimore, Md. : 1950.
3. Bartholdi, D., and M.E. Schwab. 1997. Expression of pro-inflammatory cytokine and chemokine mRNA upon experimental spinal cord injury in mouse: an in situ hybridization study. European Journal of Neuroscience 9: 1422-1438. (Pubitemid 27303243)
4. Barone, F.C., and G.Z. Feuerstein. 1999. Inflammatory mediators and stroke: new opportunities for novel therapeutics. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 19: 819-834. (Pubitemid 30173383)
5. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.
6. Chronidou, F., E. Apostolakis, I. Papapostolou, K. Grintzalis, C.D. Georgiou, E.N. Koletsis, M. Karanikolas, P. Papathanasopoulos, and D. Dougenis. 2009. Beneficial effect of the oxygen free radical scavenger amifostine (WR-2721) on spinal cord ischemia/reperfusion injury in rabbits. Journal of Cardiothoracic Surgery 4: 50.
7. Clark, W.M., L.G. Rinker, N.S. Lessov, S.L. Lowery, and M.J. Cipolla. 2001. Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke: A Journal of Cerebral Circulation 32: 1000-1004. (Pubitemid 32285174)
8. Dinarello, Charles A. 2004. Interleukin-18 and the treatment of rheumatoid arthritis. Rheumatic Diseases Clinics of North America 30: 417-434.
9. Dolgun, Habibullah, Sekerci Zeki, Turkoglu Erhan, Kertmen Hayri, Erdal R. Yilmaz, Anlar Murat, Imge B. Erguder, and Tuna Hakan. 2010. Neuroprotective effect of mesna (2-mercaptoethane sulfonate) against spinal cord ischemia/reperfusion injury in rabbits. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 17: 486-489.
10. Dumont, R.J., D.O. Okonkwo, S. Verma, R.J. Hurlbert, P.T. Boulos, D.B. Ellegala, and A.S. Dumont. 2001. Acute spinal cord injury. Part I: pathophysiologic mechanisms. Clinical Neuropharmacology 24: 254-264. (Pubitemid 32906712)
11. Emmanuilidis, Klaus, Weighardt Heike, Matevossian Edouard, Heidecke Claus-Dieter, Ulm Kurt, Bartels Holger, Siewert Jörg-Rüdiger, and Holzmann Bernhard. 2002. Differential regulation of systemic IL-18 and IL-12 release during postoperative sepsis: high serum IL-18 as an early predictive indicator of lethal outcome. Shock 18: 301-305. Augusta, GA.
12. Erşahin, Mehmet, Hale Z. Toklu, Cetinel Sule, Yüksel Meral, Erzik Can, M. Zafer Berkman, Berrak C. Yeǧen, and Sener Göksel. 2010. Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage. Neurochemical Research 35: 418-428.
13. Genovese, T., and S. Cuzzocrea. 2008. Role of free radicals and poly(ADP-ribose)polymerase-1 in the development of spinal cord injury: new potential therapeutic targets. Current Medicinal Chemistry 15: 477-487. (Pubitemid 351472414)
14. Harrington, J.F., A.A. Messier, A. Levine, J. Szmydynger-Chodobska, and A. Chodobski. 2005. Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. Journal of Neurotrauma 22: 919-928. (Pubitemid 41153876)
15. Hasturk, A., B. Atalay, T. Calisaneller, O. Ozdemir, H. Oruckaptan, and N. Altinors. 2009. Analysis of serum proinflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue damage. Turkish Neurosurgery 19: 353-359.
16. Hayashi, M., T. Ueyama, K. Nemoto, T. Tamaki, and E. Senba. 2000. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. Journal of Neurotrauma 17: 203-218. (Pubitemid 30174159)
17. Hayashi, T., M. Sakurai, K. Abe, M. Sadahiro, K. Tabayashi, and Y. Itoyama. 1998. Apoptosis of motor neurons with induction of caspases in the spinal cord after ischemia. Stroke: A Journal of Cerebral Circulation 29: 1007-1012. discussion 1013.
18. Ismailoglu, O., B. Oral, R. Sutcu, Y. Kara, O. Tomruk, and N. Demir. 2013. Neuroprotective effects of raloxifene on experimental spinal cord injury in rats. American Journal of the Medical Sciences 345: 39-44.
19. Junk, Anna K., Mammis Antonios, Sean I. Savitz, Singh Manjeet, Roth Steven, Malhotra Samit, Pearl S. Rosenbaum, Cerami Anthony, Brines Michael, and Daniel M. Rosenbaum. 2002. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proceedings of the National Academy of Sciences of the United States of America 99: 10659-10664.
20. Keane, R.W., S. Kraydieh, G. Lotocki, J.R. Bethea, S. Krajewski, J.C. Reed, and W.D. Dietrich. 2001. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. Journal of Neuropathology and Experimental Neurology 60: 422-429. (Pubitemid 32467099)
21. Kertmen, H., B. Gurer, E.R. Yilmaz, A.M. Sanli, M. Sorar, A.T. Arikok, M.F. Sargon, M.A. Kanat, B.I. Erguder, and Z. Sekerci. 2013. The protective effect of low-dose methotrexate on ischemia-reperfusion injury of the rabbit spinal cord. European Journal of Pharmacology 714: 148-156.
22. Ludwiczek, Othmar, Arthur Kaser, Daniela Novick, A. Charles, Menachem Rubinstein Dinarello, Wolfgang Vogel, and Herbert Tilg. 2002. Plasma levels of interleukin-18 and interleukin-18 binding protein are elevated in patients with chronic liver disease. Journal of Clinical Immunology 22: 331-337.
23. Mallat, Z., P. Henry, R. Fressonnet, S. Alouani, A. Scoazec, P. Beaufils, Y. Chvatchko, and A. Tedgui. 2002. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart 88: 467-469. (Pubitemid 35221955)
24. McGuinness, P.H., D. Painter, S. Davies, and G.W. McCaughan. 2000. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection. Gut 46: 260-269. (Pubitemid 30305855)
25. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annual Review of Immunology 19: 423-474. (Pubitemid 32368042)
26. Nakanishi, K., T. Yoshimoto, H. Tsutsui, and H. Okamura. 2001. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine & Growth Factor Reviews 12: 53-72. (Pubitemid 32294587)
27. Novick, D., S.H. Kim, G. Fantuzzi, L.L. Reznikov, C.A. Dinarello, and M. Rubinstein. 1999. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10: 127-136. (Pubitemid 29077390)
28. Ono, Shigeshi, Hideaki Obara, Atsushi Takayanagi, Minoru Tanabe, Shigeyuki Kawachi, Osamu Itano, Masahiro Shinoda, et al. 2011. Suppressive effects of interleukin-18 on liver function in rat liver allografts. The Journal of Surgical Research 176(1): 293-300.
29. Oruckaptan, H.H., P. Ozisik, P. Atilla, M. Tuncel, K. Kilinc, P.O. Geyik, N. Basaran, E. Yuksel, and O.E. Ozcan. 2009. Systemic administration of interleukin-10 attenuates early ischemic response following spinal cord ischemia reperfusion injury in rats. Journal of Surgical Research 155: 345-356.
30. Sakao, Y., K. Takeda, H. Tsutsui, T. Kaisho, F. Nomura, H. Okamura, K. Nakanishi, and S. Akira. 1999. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. International Immunology 11: 471-480. (Pubitemid 29121634)
31. Schöning, B., P. Elepfandt, W.R. Lanksch, H.D. Volk, and C. Woiciechowsky. 1999. Continuous infusion of proinflammatory cytokines into the brain to study brain cytokine induced local and systemic immune effects. Brain Research Protocols 4: 217-222. (Pubitemid 29396422)
32. Seekamp, A., M. Jochum, M. Ziegler, M. van Griensven, M. Martin, and G. Regel. 1998. Cytokines and adhesion molecules in elective and accidental trauma-related ischemia/reperfusion. The Journal of Trauma 44: 874-882. (Pubitemid 28233037)
33. Shen, Qin, Dan Zhou, Zhiyun Ben, Chun Cheng, Yonghua Liu, and Aiguo Shen. 2008. Lipopolysaccharide-induced upregulation of tumor necrosis factor-alpha (TNF-alpha) in rat spinal cord. Inflammation 31: 336-343.
34. Taupin, V., S. Toulmond, A. Serrano, J. Benavides, and F. Zavala. 1993. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. Journal of Neuroimmunology 42: 177-185.
35. Tetik, O., F. Islamoglu, T. Yagdi, Y. Atay, T. Calkavur, C. Ozbek, L. Canpolat, S. Büket, and M. Vüksel. 2001. An intraaortic solution trial to prevent spinal cord injury in a rabbit model. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 22: 175-179. (Pubitemid 32737464)
36. Tsutsui, H., K. Matsui, N. Kawada, Y. Hyodo, N. Hayashi, H. Okamura, K. Higashino, and K. Nakanishi. 1997. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. Journal of Immunology 159: 3961-3967. Baltimore, MD.: 1950.
37. Tsutsui, H., K. Matsui, H. Okamura, and K. Nakanishi. 2000. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunological Reviews 174: 192-209. (Pubitemid 30201389)
38. Wang, C.X., B. Nuttin, H. Heremans, R. Dom, and J. Gybels. 1996. Production of tumor necrosis factor in spinal cord following traumatic injury in rats. Journal of Neuroimmunology 69: 151-156. (Pubitemid 26305640)
39. Wang, J., Q. Long, W. Zhang, and N. Chen. 2012. Protective effects of exogenous interleukin 18-binding protein in a rat model of acute renal ischemia-reperfusion injury. Shock 37: 333-340.
40. Yilmaz, Erdal Resit, Hayri Kertmen, Habibullah Dolgun, Bora Gürer, Ahmet Metin Sanli, Mehmet Ali Kanat, Ata Türker Arikok, Seda Yilmaz Bahsi, Berrin Imge Ergüder, and Zeki Sekerci. 2012. Effects of darbepoetin-α in spinal cord ischemia-reperfusion injury in the rabbit. Acta Neurochirurgica 154: 1037-1043. discussion 1043-4.